Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
The Journal of Biological Chemistry|July 10, 2012
α-Galactosidase aggregation is a determinant of pharmacological chaperone efficacy on Fabry disease mutantsAleksandra Siekierska, Greet De Baets, Joke Reumers, et al.
FEBS Letters|October 30, 2012
A comparative analysis of the aggregation behavior of amyloid-β peptide variantsAnnelies Vandersteen, Ellen Hubin, Rabia Sarroukh, et al.
The Journal of Biological Chemistry|December 14, 2011
Structural basis for increased toxicity of pathological aβ42:aβ40 ratios in Alzheimer diseaseKris Pauwels, Thomas L Williams, Kyle L Morris, et al.
NPJ Science of Food|July 31, 2024
Biopurification using non-growing microorganisms to improve plant protein ingredientsAvis Dwi Wahyu Nugroho, Saskia van Schalkwijk, Sabri Cebeci, et al.
European Journal of Medicinal Chemistry|March 26, 2015
New mimetic peptides inhibitors of Αβ aggregation. Molecular guidance for rational drug designExequiel E Barrera Guisasola, Sebastián A Andujar, Ellen Hubin, et al.
The Journal of Biological Chemistry|September 21, 2012
Molecular plasticity regulates oligomerization and cytotoxicity of the multipeptide-length amyloid-β peptide poolAnnelies Vandersteen, Marcelo F Masman, Greet De Baets, et al.
EMBO Molecular Medicine|April 19, 2011
Amyloid precursor protein mutation E682K at the alternative β-secretase cleavage β'-site increases Aβ generationLujia Zhou, Nathalie Brouwers, Iryna Benilova, et al.
Scientific Reports|June 30, 2023
The TNFR1 antagonist Atrosimab reduces neuronal loss, glial activation and memory deficits in an acute mouse model of neurodegenerationNatalia Ortí-Casañ, Ate S Boerema, Karina Köpke, et al.
Bioorganic Chemistry|August 26, 2018
Searching for improved mimetic peptides inhibitors preventing conformational transition of amyloid-β<sub>42</sub> monomerJános Gera, Titanilla Szögi, Zsolt Bozsó, et al.
Pageof 5